Pulse Biosciences (PLSE) Accumulated Expenses (2015 - 2025)

Pulse Biosciences has reported Accumulated Expenses for 11 years, with the latest figure at $2.0 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Expenses fell 71.84% year-over-year to $2.0 million; the trailing twelve-month figure through Dec 2025 stood at $2.0 million (down 71.84% YoY), and the FY2025 full-year result was $2.0 million, down 71.84% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $2.0 million, down from $5.2 million in the prior quarter.
• The five-year high for Accumulated Expenses was $7.0 million in Q4 2024, with the low at $27000.0 in Q3 2021.
• Average Accumulated Expenses over 5 years is $2.6 million, with a median of $2.6 million recorded in 2022.
• Year-over-year, Accumulated Expenses tumbled 99.34% in 2021 and jumped 3466.0% in 2024.
• Tracing PLSE's Accumulated Expenses over 5 years: stood at $3.8 million in 2021, then slumped by 31.96% to $2.6 million in 2022, then slumped by 98.07% to $50000.0 in 2023, then jumped by 13954.0% to $7.0 million in 2024, then sank by 71.84% to $2.0 million in 2025.
• The last three Accumulated Expenses figures came in at $2.0 million (Q4 2025), $5.2 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.

Peer Comparison